These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2648782)

  • 1. 'Generic substitution' in New Jersey, 1979-87.
    Culkin TT; Mendell S
    Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH; Fassett WE; Christensen DB
    J Am Pharm Assoc (Wash); 1999; 39(5):650-7. PubMed ID: 10533346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
    Tilson L; McGowan B; Ryan M; Barry M
    Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of generic substitution in community pharmacies.
    Suh DC
    Pharm World Sci; 1999 Dec; 21(6):260-5. PubMed ID: 10658234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of competition on prescription-drug-product substitution.
    Kralewski JE; Pitt L; Dowd B
    N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.
    Andersson K; Sonesson C; Petzold M; Carlsten A; Lönnroth K
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):341-8. PubMed ID: 15624198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical ideology and product confidence: future pharmacists' attitudes toward generic drug substitution.
    Pelton LE; Smith MC
    Health Mark Q; 1991; 8(3-4):181-92. PubMed ID: 10111968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
    Andersson K; Bergström G; Petzold MG; Carlsten A
    Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.
    Kalisch LM; Roughead EE; Gilbert AL
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):620-5. PubMed ID: 18324613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: prescribers' concerns.
    McGettigan P; McManus J; O'Shea B; Chan R; Feely J
    Ir Med J; 1997; 90(4):146-7. PubMed ID: 9267094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia.
    Ping CC; Bahari MB; Hassali MA
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):82-9. PubMed ID: 17879323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generic drug prescriptions following hospital discharge: a prospective study in France.
    Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
    Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution.
    Gumbs PD; Verschuren WM; Souverein PC; Mantel-Teeuwisse AK; de Wit GA; de Boer A; Klungel OH
    Br J Clin Pharmacol; 2007 Nov; 64(5):680-5. PubMed ID: 17875197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Generic drug substitution].
    Tamir O; Halkin H; Shemer J
    Harefuah; 2006 Sep; 145(9):691-5, 701. PubMed ID: 17078434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.